Abelson murine leukemia virus (A-MuLV) encodes an oncogenic form of the Abelson kinase, v-Abl (Risser and Green 1988) . v-Abl is a fusion protein in which portions of the retroviral Gag protein replace the amino-terminal SH3 domain of c-Abl, rendering the tyrosine kinase activity constitutive. Until recently, little was known about functionally important substrates of the Abelson kinases or about possible signal transduction paths which their action might initiate. Development of temperature-sensitive forms of v-Abl led to the identification of the c-myc gene as an important target of v-Abl activity. In fibroblasts, myeloid cells, and pre-B cells, vAbl induces transcription of c-myc which is independent of new protein synthesis, suggesting that v-Abl acts by post-translational modification of existing c-myc regulatory proteins (Cleveland et al. 1989; Chen and Rosenberg 1992; Renshaw et al. 1992 ). Subsequently, dominantnegative forms of c-Myc were used to show that c-Myc was required for transformation by either v-abl or bcr/ abl, establishing the importance of the c-myc gene as an ultimate target for the activity of v-Abl and BCR/ABL tSawyers et al. 1992).
We have been studying v-Abl-dependent induction of c-myc transcription as a way of gaining further under-
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standing of this critical aspect of v-Abl signaling. Our previous work showed that v-Abl can induce c-myc transcription through the E2F site located upstream of the P2 transcription initiation site in the c-myc promoter. We showed further that E2F sites alone are sufficient to confer v-Abl reponsiveness on a heterologous promoter . This induction requires the SH1 (kinase) and SH2 domains of v-Abl but does not require the carboxy-terminal nuclear localization signal, SH3 binding, DNA-binding, or actin-binding domains . Thus, v-Abl appears to induce c-myc transcription by initiating a phosphorylation cascade that ultimately increases the transcriptional activating ability of E2F site binding proteins. Because we knew that the initial signal for c-myc transcriptional induction came from vAbl tyrosine kinase and the penultimate event was activation of E2F-dependent transcription, we wanted to determine the intermediate biochemical steps in this signal transduction pathway.
In this study we have determined the components of the signaling pathway that links v-Abl and induction of c-myc transcription. The roles of the Ras GTPase, Rafl serine/threonine kinase, and Rac GTPase were assessed by cotransfecting a series of dominant-negative and constitutively active mutants, v-Abl induces c-myc transcription via a pathway that requires Ras and Rafl, but not Rac. Furthermore, we show that overexpression of p21, an inhibitor of cyclin-dependent kinases (cdks), blocks v-Abl-dependent induction of c-myc transcription. Consistent with this finding, v-Abl causes activation of cdk2 and cdk4 and hyperphosphorylation of the retinoblastoma (Rb) protein, p107, and p130. We propose that v-Abl-dependent activation of Rafl is linked to activation of cdk2/cdk4 through the recently identified cdc25 pathway. Thus, these studies have resulted in the identification of the major components of a signaling pathway between v-Abl and one of its functionally important target genes, c-myc.
Results

Ras GTPase and Rafl Ser/Thr kinase are required for the induction of c-myc transcription by v-AbI
Our previous work suggested that induction of c-myc transcription by v-Abl depended on initiation of a phosphorylation cascade . We wondered if this pathway involved activation of Ras which, like induction of c-myc (Sawyers et al. 1992) , is required for Abl-dependent transformation (Goga et al. 1995; Sawyers et al. 1995) . To test this hypothesis, we utilized our previously developed cotransfection assay . A v-Abl expression plasmid (pAB160-19) and a luciferase reporter (Luc) dependent on the murine c-myc promoter (extending from nucleotide -140 to nucleotide +340) were cotransfected into 4A2 fibroblasts (Renshaw et al. 1992 ) with or without a plasmid encoding a dominant-interfering mutant of Ras, Ras N17 (Stacey et al. 1991) . v-Abl activated the c-myc promoter reporter approximately six-to sevenfold compared to the appropriate control lacking v-abl cDNA (Fig. 1A, lanes 1,2) . However, in the presence of dominant-negative Ras N17, vAbl-dependent activation was ablated completely (Fig.  1A, lanes 3,4) . We then tested the effect of cotransfecting a plasmid encoding a constitutively active Ras mutant, Ras V12 (Conrad and Gutierrez-Hartmann 1992) . Ras V 12 activated c-myc transcription, and v-Abl was unable to activate it further in the presence of Ras V12 (Fig. 1A,  lanes 5,6) . These results show that Ras GTPase activity is required downstream of v-Abl for v-Abl to activate c-myc transcription.
The Ser/Thr kinase Rafl is an immediate downstream effector for many Ras-dependent events (Marshall 1995) . Therefore, we used the same approach to ask whether Rafl was also required for v-Abl-dependent activation of c-myc transcription. Expression of RafC4, a dominantnegative form of Rafl (Bruder et al. 1992) , efficiently inhibited activation of the c-myc promoter by v-Abl (Fig.  1B lanes 3,4) . In addition, a constitutively active mutant Cold Spring Harbor Laboratory Press on November 2, 2017 -Published by genesdev.cshlp.org Downloaded from of Rafl, RafBXB (Bruder et al. 1992) activates the c-myc promoter alone and there is no further activation with v-Abl (Fig. 1B, lanes 5,6) . We also found that dominantnegative forms of Ras and Rafl blocked v-Abl-dependent activation of a truncated c-myc promoter reporter construct, +70/+160Luc (Fig. 1C) , and a minimal TATA box dependent on four E2F-binding sites (data not shown). In these templates the response to v-Abl depends solely on the E2F sites .
We wished to be sure that expression of dominantnegative forms of Ras and Rafl did not inhibit activation of c-myc transcription nonspecifically. Therefore, we tested the ability of the p65 subuint of NF-KB to activate the c-myc promoter in the absence or presence of dominant-negative Ras or Rafl, as NF-KB activation does not involve Ras or Raf and we have shown previously that NF-KB sites are not involved in activation of c-myc by v-Abl . We cotransfected a p65 expression plasmid with -1100/+580Luc, a larger c-myc promoter reporter construct which contains the two NF-KB responsive sites (Duyao et al. 1990 a,b) , into 4A2 cells. p65 activated this reporter approximately fivefold (Fig.  1D, lanes 1,2) . In the presence of dominant-negative Ras N17 (Fig. 1D, lanes 3,4) or dominant-negative RafC4 (Fig.  1D , lanes 5,6), p65 still fully activated c-myc transcription. Thus, we conclude that inhibition of v-Abl-dependent activation of c-myc transcription by Ras N17 and RafC4 is specific. Taken together, these data demonstrate that activation of Ras and Rafl Ser/Thr kinase is required as a downstream effector for v-Abl-dependent trans-activation of c-myc transcription.
Activity of the Rac GTPase is not required for v-Abl to activate c-myc transcription
The v-Abl tyrosine kinase apparently uses more than one independent signaling pathway to transform cells. It has been shown that Rac and Ras are both important for v-Abl to activate mitogenesis, and a dominant-negative Rac mutant can inhibit v-Abl-induced activation of the TPA response element (TRE) and the serum response element (SRE) (Renshaw et al. 1996 ). Therefore, we tested whether Rac activity is required for v-Abl to activate c-myc transcription. In the cotransfection assay shown in Figure 2 , v-Abl activated the c-myc promoter reporter approximately sixfold ( Fig. 2A, lanes 1,2) ; however, in contrast to the results using dominant-negative forms of Ras and Raf, this activation was fully retained in the presence of an expression plasmid encoding dominant-negative Rac, V12N17racl (Ridley et al. 1992) (Fig.  2A, lanes 3,4) . The activity of cotransfected V12N17racl in our system was confirmed by its ability to inhibit v-Abl-dependent activation of an SRE-dependent promoter (Fig. 2B , cf. lanes 3 and 4 with lanes 1 and 2) as reported previously (Renshaw et al. 1996) . Thus, we conclude that Rac activity is not required for v-Abl to transactivate c-myc transcription in our system.
v-Abl activates cdks
Because v-Abl activation of c-myc transcription requires the E2F site, we assume that E2F site binding proteins are activated in response to v-Abl. The activity of E2F-DP heterodimers is modulated by association with Rb family proteins and the ability of Rb family proteins to associate is regulated by phosphorylation (Adams and Kaelin 1995; Chen et al. 1995; Weinberg 1995; Cobrinik 1996) . Rb family proteins are phosphorylated by cdks: cdk4-cyclin D is active early in G1, and cdk2-cyclinE is active later in G1 (Weinberg 1995) . Therefore, we asked whether cdk activity changed in response to v-Abl signaling.
We took advantage of the D5 cell line, a 3T3 subclone transformed with a temperature-sensitive form of v-Abl (Renshaw et al. 1992) . At the permissive temperature (32°C), D5 cells are transformed, displaying serum-and anchorage-independent growth and increased transcription of their endogenous c-myc gene. At the nonpermissive temperature (39°C1, the cells revert to serum-and anchorage-dependent growth typical of 3T3 cells. D5 cells were made quiescent by serum starvation at 39°C for 48 hr. Subsequently the temperature was shifted to 32°C to activate v-Abl; under these conditions, growth is dependent solely on v-Abl, as the cells are still serum starved. We also compared cells growing in serum at the permissive and nonpermissive temperatures; at the permissive temperature these cells are receiving signals from both v-Abl and serum. Immunoprecipitated v-Abl was immunoblotted with antibody to phosphotyrosine to confirm that v-Abl kinase was temperature sensitive in our system (Fig. 3A, panel a) . D-type cyclin-associated kinase activity was assayed in vitro by immunoprecipitating with cyclin D 1 antibodies at various time following temperature shift, and the associated kinase activity was assayed by using glutathione S-transferase (GST)-Rb protein substrates. This activity primarily belongs to cdk4, as cdk4 is the major partner of D-type cyclin complexes in fibroblasts (Matsushime et al. 1994) . A small but reproducible increase (twofold) in kinase activity was observed following activation of v-Abl in the absence of serum (Fig. 3A, panel b) . D-type cyclin activity was increased at both temperatures in the presence of serum, although it was slightly higher at the permissive temperature. In all cases, the amount of cdk4 protein, determined by immunoblot (Fig. 3A, panel c) , did not change significantly.
Cdk2 activity was similarly assayed in vitro using histone H1 as substrate. An increase in cdk2 activity was observed at 2 hr and reached 5.7-fold by 8 hr (Fig. 3A,  panel d ). Cdk2 activity was elevated at both temperatures in the presence of serum, although activity was slightly higher in the presence of v-Abl. The amount of cdk2 protein, determined by immunoblot (Fig. 3A , panel e), did not change significantly in any sample. Thus, we observe a v-Abl-dependent increase in cdk activity, especially for cdk2, which is consistent with the possiblity of v-Abl-dependent phosphorylation of Rb family proteins and subsequent activation of E2F proteins.
Cdk activity is required for v-Abl-dependent induction of c-myc transcription
To test directly whether cdk activity is required for vAbl-dependent induction of c-myc transcription, we expressed p21 in the cotransfection assay along with v-Abl and the reporter dependent on the c-myc promoter, p21 is a universal inhibitor of cdk activity (Xiong et al. 1993 ).
v-Abl activated the -140/+340Luc c-myc promoter reporter approximately sixfold (Fig. 3B, lane 1,2) ; however, in the presence of p21, this activation was ablated completely (Fig. 3B, lane 3,4) . As a control, we examined the effect of p21 on v-Abl-dependent activation of a reporter dependent on an SRE. Because v-Abl-dependent activation of a SRE requires Rac ( Fig. 2 ; Renshaw et al. 1996) , it appears to proceed by a different signal transduction
on c-fos SRE) more than sixfold (Fig. 3C, lanes  1,2) , and this activation was not affected by cotransfection of the p21 expression plasmid (Fig 3C, lanes 3,4) . Thus, inhibition of v-Abl-dependent induction by p21 expression is specific for c-myc transcription and is not required for SRE-dependent transcription. We conclude that cdk activity is required for trans-activation of c-myc transcription by v-Abl.
Rb family proteins are hyperphosphorylated in response to v-Abl signaling
Because Rb family proteins are primary substrates of the cdks, as well as regulators of E2F proteins, we examined the phosphorylation states of pRb, p107, and p130 in D5 cells. Hypophosphorylated forms of pRb, p107, or p130 migrate faster in SDS-polyacrylamide gels than hyperphosphorylated forms and can be discerned using immunoblots. Cells were grown at both temperatures in the absence of serum as described above. Whole-cell extracts were prepared from these cells, and immunoblots were analyzed with antisera against c-Myc, pRb, p107, and p130. Activation of the v-Abl tyrosine kinase (Fig. 4A , panel a) led to an increase in c-Myc (Fig. 4A, panel b) , consistent with previous reports (Renshaw et al. 1992) and thereby demonstrating that v-Abl was signaling correctly. Before temperature shift, approximately half of the pRb was in the high-mobility hypophosphorylated form; after temperature shift, nearly all was found in the low-mobility hyperphosphorylated form (Fig. 4A, panel  c) . Similarly, p 107 became increasingly hyperphosphorylated, as evidenced by lower mobility, following v-Abl activation by temperature shift (Fig. 4A, panel d) . Of the three family members, the phosphorylation state of p 130 changed most dramatically. At the nonpermissive temperature, p130 was in two higher mobility hypophosphorylated forms; 8 hr after temperature shift, p130 was entirely in a lower mobility hyperphosphorylated form (Fig. 4A, panel e) . In addition, less p130 was observed 8 hr after temperature shift, although we do not know whether the amount actually decreased or whether the hyperphosphorylated form reacts less well with antiserum. We conclude that pRb, p107, and p130 are hyperphosphorylated in response to v-Abl signaling and that the amount of p130 may decrease in response to v-Abl.
Overexpression of pRb blocks v-Abl-dependent induction of c-myc transcription
Association of E2F-DP heterodimers with pRb, p107, and/or p130 inhibits their ability to act as transcriptional activators and can create transcriptional repressors (Cobrinik 1996) . Thus, our results are consistent with a model in which v-Abl signaling results in activation of cdks, phosphorylation of Rb family proteins, release of Rb proteins from association with E2F-DP and, finally, activation of c-myc transcription via the E2F site. To examine this model further, we used the cotransfection assay to test whether overexpression of pRb could block v-Abl-dependent trans-activation of c-myc transcription. Our results show that ectopic pRb does block c-myc transcription in this assay (Fig. 4B , cf. lanes 3 and 4 with lanes 1 and 2). As a control, we examined the effect of pRb on v-Abl-dependent activation of a reporter dependent on a SRE; this activation was not affected by cotransfection of the Rb expression plasmid (Fig. 4C , cf. lanes 3 and 4 with lanes 1 and 2). These results are consistent with the idea that c-myc transcription is sensitive to the levels of hypophosphorylated pRb and lend support to the suggestion that v-Abl activation via E2F sites depends on phosphorylation of Rb family proteins. . In this study we have identified key components of the signaling pathway between v-Abl and activated E2F site binding proteins. We propose that v-Abl induces c-myc transcription by the pathway illustrated in Figure 5 . This path is not the only signaling pathway that v-Abl utilizes to carry out its full program of cell transformation and may not be the only path used to induce c-myc. However, this represents the most complete understanding to date of a signaling pathway from v-Abl to a functionally important target gene.
Ras and Rafl are required for v-Abl-dependent induction of c-myc
A requirement for the Ras GTPase in v-Abl-dependent induction of c-myc is consistent with previous data showing that both Ras and c-Myc are required for v-Abland BCR/ABL-dependent transformation (Smith et al. 1986; Sawyers et al. 1992 Sawyers et al. , 1995 . Although v-Abl and BCR/ABL activate Ras via adaptor proteins that associate with BCR sequences (Pendergast et al. 1993) or the proline-rich SH3-binding domain (SBD) in the carboxyl terminus (Feller et al. 1994; Nichols et al. 1994; Ren et al. 1994; Goga et al. 1995) , we believe that association of v-Abl with Shc, which requires the v-Abl SH2 domain (Raffel et al. 1996) , is critical for activation of E2F proteins. The SH2 domain, but not the SBD of v-Abl, is required for v-Abl-dependent trans-activation of c-myc transcription , and c-Myc complements mutations in the SH2 domain of BCR/ABL in a transformation assay (Afar et al. 1994 ). However, our data do not rule out the possibility (broken line in Fig. 5 ) that activation of Ras by an adaptor such as Crkl may be an alternate path by which v-Abl induces c-myc transcription via Ras.
E2F activation by v-Abl does not require Rac
While c-Myc is required for v-Abl-dependent transformation, its induction is not sufficient for transformation (Sawyers et al. 1992 ). The Ras-related GTPase Rac has been shown to be necessary for activation of a mitogenic program by v-Abl (Renshaw et al. 1996) . Rac is required for induction of TRE-dependent transcription by v-Abl, whereas Rac, Ras, and Rafl are required for v-Abl to induce SRE-dependent transcription (Renshaw et al. 1996) . We show that Ras and Rafl, but not Rac, are required for v-Abl to induce the c-myc promoter. This emphasizes that v-Abl-dependent induction of promoters containing SREs and TREs (presumably corresponding to c-fos and c-jun, respectively in vivo) proceeds by pathways distinct from that for c-myc and is consistent with the facts that neither the c-fos nor the c-jun promoter is regulated by E2F sites and that v-Abl increases expression of c-Myc but not Fos or JunB in a myeloid line (Cleveland et al. 1989 ).
Cdc25 may link v-Abl-dependent activation of Rafl to activation of cdks
Our work and that of others suggests that mitogen-activated protein kinase (MAPK) may not be involved in E2F site-dependent activation by v-Abl via Rafl. Dominantnegative Rac inhibits v-Abl-dependent activation of MAPK (Renshaw et al. 1996) but fails to block v-Abldependent induction of c-myc transcription (Fig. 2) . In addition, a synthetic inhibitor of the MAPK pathway, PD 098059 (Dudley et al. 1995) failed to inhibit v-Abl transactivation of c-myc in our standard assay (data not shown). Finally, in the murine mast cell line ICDP, vAbl induces Shc phosphorylation but not MAPK activation (Owen-Lynch et al. 1995) . We suggest, but have not yet demonstrated, that v-Abl is linked to activation of E2F proteins via a second path from Rafl that involves the cdc25A phosphatase, cdc25 activates cdc2 and cdk2 by dephosphorylating a critical tyrosine (Y15) in their nucleotide-binding domains (Jinno et al. 1994; Galaktionov et al. 1995) . cdk4 and cdk6 may also be activated by cdc25 because this tyrosine in their nucleotide-binding domains is conserved (Terada et al. 1995) .
cdks are required for v-Abl-dependent induction of c-myc transcription cdk inhibitor p21 specifically blocked the v-Abl-depen-Cold Spring Harbor Laboratory Press on November 2, 2017 -Published by genesdev.cshlp.org Downloaded from dent induction of c-myc transcription but not induction of an SRE-dependent promoter (Fig. 3B, C) , demonstrating that cdk activity is required for v-Abl-dependent trans-activation of c-myc transcription. This is corroborated by increased activity of cdk2 and cdk4 when D5 cells are signaled by v-Abl to proliferate (Fig. 3A) . cdk2 can form complexes with both E2F-pl07 and E2F-pl30. These higher-order complexes may be intermediates whose subsequent disruption yields free, active E2F-DP heterodimers (Zhu et al. 1995; Shiyanov et al. 1996) . This possibility is consistent with the fact that cdk2-containing E2F complexes are seen during S phase in normal cells but are observed throughout the cell cycle in v-Abltransformed D5 cells . Alternatively, activated cdk2 may directly phosphorylate pocket proteins associated with E2F-DP heterodimers and release free E2F-DP heterodimers.
Hyperphosphorylation of Rb family proteins appears to be important for v-Abl-dependent induction of c-myc transcription
The penultimate step in v-Abl-dependent induction of c-myc via the E2F site is a functional change in proteins that bind the E2F site. Upon association with Rb family "pocket proteins" the ability of E2F-DP heterodimers to activate transcription is ablated or changed to repression. Hyperphosphorylation releases pocket proteins and changes the activity of E2F-DP heterodimers (Chellapan 1994; Cobrinik 1996; Slansky and Farnham 1996} . Our demonstration (Fig. 4A ) that v-Abl signaling leads to hyperphosphorylation of pRb, p 107, and p 130 is consistent with the idea that release of Rb family proteins from E2F-DP heterodimers is a critical step for induction of c-myc via the E2F site (Fig. 5) . However, we cannot distinguish whether the actual mechanism of this induction is activation (by E2F-DP heterodimers), relief of repression (removal of E2F-DP-Rb complexes), or both.
pRb, p107, and p130 each bind to particular members of the E2F family at distinct stages of the cell cycle and act in concert to limit the activation of E2F and the expression of E2F-responsive genes (Vairo et al. 1995; Weinberg 1995; Shiyanov et al. 1996) . Our data do not distinguish specific roles for individual pocket proteins in the v-Abl-dependent induction of c-myc transcription. Although pRb repressed c-myc promoter activity in the cotransfection assay (Fig. 4B) , this does not establish a key role for pRb in vivo, as overexpression of any pocket protein would be expected to alter the balance between active and inactivate E2F-binding proteins.
Autoregulatory loops
c-Myc/Max was recently shown to activate transcription of cdc25A at a time in G 1 when c-Myc induction peaks (Galaktionov et al. 1996) . This is consistent with previous work showing that c-Myc stimulates the activity of cyclin E-and Dl-dependent kinases, possibly via cdc25, and leads to hyperphosphorylation of pRb (Steiner et al. 1995) . c-Myc has also been reported to activate transcription of cyclin A and D1, and there are binding sites for c-Myc/Max in the E2F-1 promoter (Jansen-Durr et al. 1993; Johnson et al. 1994) . If v-Abl activated E2F proteins by another Ras/Raf-dependent path, elevated c-Myc could induce transcription of cdc25, cyclin D 1, cyclin A, and/or E2F-1. In this model c-Myc induction would cause and not result from increased cdk activity, hyperphosphorylation of pocket proteins, and altered E2F-binding proteins. However, this model is not consistent with our observation that p21 blocks the ability of v-Abl to trans-activate c-myc, which establishes a requirement for cdk activity in the path from v-Abl to c-myc. We favor the view that v-Abl leads to a dynamic situation with autoregulatory loops in which c-Myc, cdc25, cdks, and E2F-1 can be both regulators and subject to regulation.
Our data provide the most complete understanding to date of a signaling pathway initiated by v-Abl and raise important questions for further investigation. For example, a role for cdc25A and the prediction that other E2F-dependent genes may be activated by v-Abl or that other cdc25-or p21-regulated proteins may be sensitve to v-Abl signaling can be tested. Experiments can be designed to ask whether signaling by v-Abl mimics a normal proliferative signal or whether there are qualitative or quantitative differences in activation of specific proteins in the path. Finally, we can ask how v-Abl signaling may be related to signaling by BCR/ABL or c-Abl.
Materials and methods
Cells and transfections
Monolayer culture of 4A2 (P-3T3) and D5 fibroblasts were grown in Iscove's modified Dulbecco's medium containing 10% newborn calf serum. DNA transfection was performed by the calcium phosphate precipitation method described by Chen and Ohayama (1988) . Cells (5 x 105) were seeded 1 day prior to transfection and fed with fresh medium 3 hr before transfection. The cells were usually transfected with 5 ~g of reporter plasmid and 5 pg of each expression plasmid unless indicated otherwise, and the total amount of transfected DNA was balanced by pUC19 plasmid. After an overnight incubation, the cells were washed, transferred to medium containing 0.5% serum, and harvested 96 hr later, or transferred to medium containing 0.2% serum and harvested 24 hr later. Luciferase activity for each transfection was measured as described previously (Riggs et al. 1993 ).
Plasmids
The c-myc promoter reporters -1100/+580Luc, -140/+340Luc, and +70/+160Luc have been described previously . The plasmid expressing v-Abl, pAB 160-19, and pLTR promoter control plasmid have also been described previously . Plasmid Ras N17, expressing the dominantnegative Ras, was kindly provided by A. M. Pendergast and has been described previously (Pendergast et al. 1993) . Plasmid Ras V12, expressing the constitutive active Ras, was kindly provided by A. Gutierrez-Hartmann and has been described previously (Conrad and Gutierrez-Hartmann 1992) . The plasmids expressing dominant-negative and constitutive active mutants of Raf, RafC4, and RafBXB were kindly provided by U.R. Rapp and have been described previously (Bruder et al. 1992 ). Plasmid V12N 17rac 1, expressing dominant-negative Rac, was a gift from A. Hall and has been described previously (Ridley et al. 1992) . Plasmid CMVp21 was kindly provided by S.J. Elledge and described previously (Harper et al. 1993) . Plasmid p65 was kindly provided by D. Baltimore (Massachusetts Institute of Technology, Cambridge). Plasmid pSV-Rb, an expression construct of Rb, was kindly provided by S.P. Goff (Columbia University). Plasmid SRE-Fluc was kindly provided by R. Prywes and described previously (Johansen and Prywes 1994) .
Immunoprecipitation and kinase assays
For immunoprecipitation, cells were washed twice with icecold PBS, harvested in lysis buffer containing 50 mM HEPES (pH 7.5), 10% glycerol, 150 mM NaCI, 1 mM EDTA, 2.5 mM EGTA, 1 mM DTT, and 0.1% Tween 20, supplemented with the phosphatase and protease inhibitors 1.0 mM NaF, 0.1 mM sodium orthovanadate, 5 ~g of leupeptin per ml, 10 Bg of aprotinin per ml, 5 ~g of pepstatin A per ml, and 1.0 mM PMSF and lysed by repeated passage through a 25-gauge needle. Cellular debris was removed from soluble extracts by centrifugation at 16,000g for 10 min at 4°C. Lysates were precleared by incubation with protein A(G)-agarose (Santa Cruz Biotechnology) for 30 min at 4°C. Endogenous cdk2-containing complexes were immunoprecipitated for 2 hr at 4°C using 1 ~g cdk2 antibody and then incubated with 20 ~1 of protein A-agarose beads (50% vol/vol) for 2 hr at 4°C. Immunoprecipitates were washed four times with lysis buffer and twice with the kinase reaction buffer (50 mM HEPES at pH 7.5, 10 mM MgCl~, 1 mM DTT, 2.5 mM EGTA). The kinase activity associated with anti-cdk2 immunocomplexes was assayed in 30 ~1 of kinase reaction buffer containing 5 ~g of histone H1 (Boehringer Mannheim), 5 ~Ci of [~-32p]ATP. Reactions were carried out for 15 min at 30°C and stopped by the addition of Laemmli sample buffer, and the reaction products were electrophoresed in a 10% SDS-polyacrylamide gel, whereupon the gels were dried, visualized by autoradiography, and quantitated with a PhosphorImager (Molecular Dynamics). Endogenous cdk4-containing complexes were immunoprecipitated using 20 B1 of protein G-agarose precoated with 2 ~g of cyclin D1 antibody. The kinase assay was performed by using 1 ktg of GST-Rb (769-921) fusion proteins (Santa Cruz Biotechnology) as the substrates. Reactions were carried out for 30 min at 30°C, the products were electrophoresed in a 10% SDS-polyacrylamide gel; and visualize and quantitated as above, v-Abl was immunoprecipitated using 5 ~l of antiserum according to standard procedure.
Western blot (immunoblot) analysis
The D5 whole-cell extracts were made the same way as the lysates for immunoprecipitation (see above). Equal amounts of cellular proteins were separated by SDS-PAGE and transferred to nitrocellulose membranes. The membranes were blotted with 5% nonfat milk in Tris buffer at pH 7.5 (50 mM Tris-HC1, 125 mM NaC1, 0.2% Tween 20) for 1 hr at room temperature and then immunoblotted with the indicated primary antibodies in 2% nonfat milk in the same Tris buffer for 2 hr at room temperature or overnight at 4°C. Antibodies immunoblotted to the membrane were detected by using horseradish peroxidaselinked secondary antibodies and an enhanced chemiluminescence detection system from Pierce (Rockford, IL).
Antibodies
To characterize proteins by immunoblot and to immunoprecipitate cdk complexes the following antibodies were used: The pRb monoclonal antibody (Q3-245) was obtained from PharMingen (San Diego, CA). The p107 (SD9), p130 (C-20), cdk2 (M2), and cdk4 (C-22) polyclonal antibodies and phosphotyrosine monoclonal antibody (PY20) were from Santa Cruz Biotechnology (Santa Cruz, CA). The cyclin D1 monoclonal antibody (DCS-11) was from NeoMarkers (Fremont, CA). Murine c-Myc antiserum was described previously (Shrivastava et al. 1996) . Antiserum against v-Abl was a gift from Dr. S. Goff.
